Advanced Medical Solutions Group PLC
LSE:AMS
Relative Value
The Relative Value of one
AMS
stock under the Base Case scenario is
152.69
GBX.
Compared to the current market price of 194.6 GBX,
Advanced Medical Solutions Group PLC
is
Overvalued by 22%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
AMS Competitors Multiples
Advanced Medical Solutions Group PLC Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| UK |
|
Advanced Medical Solutions Group PLC
LSE:AMS
|
426.6m GBP | 1.9 | 46.1 | 11.5 | 23.2 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.4T JPY | 10.2 | 37.5 | 27.1 | 32.6 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
54.5B USD | 0 | 0 | 0 | 0 | |
| CH |
|
Alcon AG
SIX:ALC
|
29.8B CHF | 3.7 | 39 | 15 | 29.1 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
101.3B DKK | 3.7 | 25.6 | 13.4 | 16 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
11.7B USD | 2.9 | 28.6 | 12.3 | 16.9 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.6B GBP | 2.6 | 36 | 14.3 | 24.4 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
41.8B CNY | 9.2 | 25.3 | 22.8 | 22.8 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.7B USD | 1.1 | -15.9 | 17 | 55.2 | |
| US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.1B USD | 3.3 | 21.9 | 14 | 17.2 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
819.6B JPY | 6.3 | 46.3 | 21.8 | 29.6 |